Study of ATH-097 in healthy volunteers
This study tests a new medicine called ATH-097 in healthy people to see how safe it is and how the body handles it. It is a first-in-human study, so participants will receive a single dose and be monitored closely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You must be in good general health.
- Your body mass index (BMI) must be between 18.5 and 29.9.
- You must not have any serious medical conditions or infections.
- You must agree to use highly effective birth control if you or your partner can have children.
- You must not smoke more than 5 cigarettes a week or use nicotine products.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called BLX-0871 in healthy adults to see how safe it is and how the body processes it. Participation may help determine the right dose for future studies, but it will not treat any existing condition.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
This study is testing a new medication called AKB-9090 for the first time in people. It will help find out how the drug works in the body and how safe it is. The study is looking for healthy volunteers.
This study tests two investigational drugs in healthy adults to see how the body absorbs, breaks down, and eliminates them, and to check for any side effects. If you are a healthy adult, you may be able to help researchers understand these drugs better.
This is an early-stage safety study testing a new drug called NHL907 in healthy volunteers. Researchers want to understand how the drug is processed by the body and confirm it is safe.
Hear when a new This is a Phase I Study Conducted in Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.